FACTORS PREDICTIVE FOR TUMOR CONTROL AMONG HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH SORAFENIB

被引：0
|
作者：
Tortora, R. [1 ]
Lanza, A. Galeota [1 ]
Lampasi, F. [1 ]
De Luca, M. [1 ]
Tartaglione, M. T. [1 ]
Pacilio, R. [1 ]
Di Costanzo, G. G. [1 ]
机构：
[1] Cardarelli Hosp, Liver Unit, Naples, Italy
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)60662-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
660
引用
收藏
页码：S266 / S266
页数：1
相关论文
共 50 条
  • [1] PREDICTIVE FACTORS FOR TUMOR CONTROL AMONG HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH SORAFENIB
    Tortora, R.
    Lanza, A. Galeota
    Lampasi, F.
    De Luca, M.
    Tartaglione, M. T.
    Pacilio, R.
    Di Costanzo, G. G.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S148 - S148
  • [2] Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib
    Vincenzi, Bruno
    Santini, Daniele
    Russo, Antonio
    Addeo, Raffaele
    Giuliani, Francesco
    Montella, Liliana
    Rizzo, Sergio
    Venditti, Olga
    Frezza, Anna Maria
    Caraglia, Michele
    Colucci, Giuseppe
    Del Prete, Salvatore
    Tonini, Giuseppe
    ONCOLOGIST, 2010, 15 (01): : 85 - 92
  • [3] Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Reis, Daniela
    Moura, Miguel
    Freitas, Luis Carlos
    Carvalhana, Sofia
    Nogueira, Paulo Jorge
    Gaio, Raquel
    Marinho, Rui Tato
    Cortez-Pinto, Helena
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E114 - E120
  • [4] Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Reis, Daniela
    Moura, Miguel
    Freitas, Luis Carlos
    Carvalhana, Sofia
    Nogueira, Paulo Jorge
    Gaio, Raquel
    Marinho, Rui Tato
    Cortez-Pinto, Helena
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E114 - E120
  • [5] Predictive significance of circulating histones in hepatocellular carcinoma patients treated with sorafenib
    Salani, Francesca
    Latarani, Maryam
    Casadei-Gardini, Andrea
    Gangadharannambiar, Priyadarsini
    Fornaro, Lorenzo
    Vivaldi, Caterina
    Pecora, Irene
    Massa, Valentina
    Marisi, Giorgia
    Canale, Matteo
    Ulivi, Paola
    Scartozzi, Mario
    Eccleston, Mark
    Masi, Gianluca
    Crea, Francesco
    EPIGENOMICS, 2022, 14 (09) : 507 - 517
  • [6] Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
    Pinter, M.
    Sieghart, W.
    Hucke, F.
    Graziadei, I.
    Vogel, W.
    Maieron, A.
    Koenigsberg, R.
    Weissmann, A.
    Kornek, G.
    Matejka, J.
    Stauber, R.
    Buder, R.
    Gruenberger, B.
    Schoeniger-Hekele, M.
    Mueller, C.
    Peck-Radosavljevic, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 949 - 959
  • [7] Sorafenib in hepatocellular carcinoma:efficacy and predictive factors
    Li Jing
    Journal of Medical Colleges of PLA, 2011, (06) : 324 - 334
  • [8] Factors Contributing to the Overall Survival in Patients with Hepatocellular Carcinoma Treated by Sorafenib
    Tsukui, Yuya
    Mochizuki, Hitoshi
    Hoshino, Yuji
    Kawakami, Satoshi
    Kuno, Toru
    Fukasawa, Yoshimitsu
    Iwamoto, Fumihiko
    Hirose, Sumio
    Yoshida, Takashi
    Hosoda, Kenji
    Suzuki, Youji
    Hosoda, Kazuhiko
    Kojima, Yuichiro
    Hirose, Yuichi
    Shindou, Kuniaki
    Matsuda, Masanori
    Yagawa, Syoji
    Tawara, Akio
    Kobayashi, Masashi
    Konishi, Toshiyuki
    Yamazaki, Takahisa
    Takahashi, Seiichiro
    Fujii, Hideki
    Enomoto, Nobuyuki
    Omata, Masao
    HEPATO-GASTROENTEROLOGY, 2012, 59 (120) : 2536 - 2539
  • [9] Predictive Factors of Tumor Recurrence and Survival in Patients with Hepatocellular Carcinoma treated with Transarterial Chemoembolization
    Cerban, Razvan
    Ester, Carmen
    Iacob, Speranta
    Grasu, Mugur
    Paslaru, Liliana
    Dumitru, Radu
    Lupescu, Ioana
    Constantin, Georgiana
    Croitoru, Adina
    Gheorghe, Liana
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2018, 27 (04) : 409 - 417
  • [10] Adjuvant sorafenib therapy in patients with resected hepatocellular carcinoma: evaluation of predictive factors
    Wei Zhang
    Gang Zhao
    Kai Wei
    Qingxiang Zhang
    Weiwei Ma
    Qiang Wu
    Ti Zhang
    Dalu Kong
    Qiang Li
    Tianqiang Song
    Medical Oncology, 2015, 32
12345